Heart Failure
In HFpEF, spironolactone confers worsening renal function but lower CV death risk
Among patients with HF with preserved ejection fraction enrolled in TOPCAT-Americas, spironolactone increased risk for worsening renal function but lowered risk for CV death regardless of renal function.
HF, COVID-19 therapies among those featured in ACC.21 late-breakers
The American College of Cardiology announced its lineup of late-breaking clinical trials selected for presentation at its virtual 2021 Scientific Session.
Comorbidities key factor in HF readmissions
Among patients with HF discharged from a hospital in Sweden, 20.3% were readmitted to the hospital within 30 days, and 60.9% were readmitted within 1 year, researchers reported.
HF-related death more prevalent within rural vs. urban communities
HF-related death was more prevalent within rural counties compared with urban counites, according to data published in PLOS ONE.
No mortality risk increase for adults hospitalized with DKA, diastolic heart failure
Diastolic heart failure did not change the mortality risk for U.S. adults hospitalized with diabetic ketoacidosis in 2016 and 2017, according to a study published in Diabetes/Metabolism Research and Reviews.
Best of February: Coffee and the heart, sacubitril/valsartan expanded indication and more
Healio and Cardiology Today have aggregated the most-read cardiology news of February.
Racial/ethnic minority groups less likely to receive optimal treatment for paroxysmal AF
Rhythm control strategies to treat paroxysmal atrial fibrillation were less common among racial/ethnic marginalized individuals than among white individuals, a cohort study published in JAMA Network Open found.
Heart failure linked to disease activity, inflammation in patients with psoriatic disease
Systemic inflammation burden and disease activity are independent risk factors for heart failure among patients with psoriatic disease, according to data published in Arthritis Care & Research.
CV involvement in malaria death may be area for diagnostic, therapeutic improvement
Due to potential underreporting of CV complications in malaria infection, consistent monitoring for and treatment of CV complications may represent unmet areas in care, researchers reported.
Ketosis may benefit cardiometabolic health in CVD
Ketosis, as achieved via ketogenic diet or supplements, may improve cardiometabolic health in patients with CVD, particularly HF, according to a review published in the Journal of the American College of Cardiology.